Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Colony-stimulating factors: present status and future applications.

J E Groopman1

  • 1Division of Hematology/Oncology, New England Deaconess Hospital, Boston, MA 02215.

Seminars in Hematology
|July 1, 1988
PubMed
Summary

Colony-stimulating factors (CSFs) are glycoprotein hormones regulating blood cell growth. Early studies show granulocyte-macrophage colony-stimulating factor effectively restores immune function in patients with certain blood disorders, with minimal toxicity.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Endocannabinoid-like N-arachidonoyl serine is a novel pro-angiogenic mediator.

British journal of pharmacology·2010
Same author

Styryl sulfonyl compounds inhibit translation of cyclin D1 in mantle cell lymphoma cells.

Oncogene·2009
Same author

Delta9-Tetrahydrocannabinol inhibits epithelial growth factor-induced lung cancer cell migration in vitro as well as its growth and metastasis in vivo.

Oncogene·2007
Same author

Evaluation of novel cell cycle inhibitors in mantle cell lymphoma.

Oncogene·2007
Same author

Stimulation of beta 1 integrin induces tyrosine phosphorylation of vascular endothelial growth factor receptor-3 and modulates cell migration.

The Journal of biological chemistry·2001
Same author

HIV-1 Tat induces microvascular endothelial apoptosis through caspase activation.

Journal of immunology (Baltimore, Md. : 1950)·2001

Area of Science:

  • Biotechnology
  • Hematology
  • Immunology

Background:

  • Recombinant DNA technology has enabled the characterization of colony-stimulating factors (CSFs).
  • CSFs are glycoprotein hormones crucial for regulating blood cell proliferation and differentiation.
  • CSFs show potential therapeutic applications in hematologic, infectious, and neoplastic disorders.

Purpose of the Study:

  • To investigate the therapeutic potential of colony-stimulating factors (CSFs).
  • To evaluate the efficacy and safety of granulocyte-macrophage colony-stimulating factor (GM-CSF) in specific patient populations.

Main Methods:

  • Utilized recombinant DNA technology for CSF characterization.
  • Administered GM-CSF to patients with acquired immune deficiency syndrome (AIDS) and myelodysplastic syndrome (MDS).

Related Experiment Videos

  • Monitored leukocyte competence and adverse effects.

    • Main Results:

    • Preliminary results indicate GM-CSF impressively restores leukocyte competence in AIDS and MDS patients.
    • Observed generally non-severe toxic effects associated with GM-CSF treatment.
    • Identified other hematopoietic factors undergoing scrutiny for clinical applications.

    Conclusions:

    • GM-CSF demonstrates significant potential in restoring immune function in compromised patients.
    • CSFs represent a promising class of therapeutic agents for various hematologic conditions.
    • Further research into hematopoietic factors may yield novel clinical treatments.